Modulators Of Dnm2 Expression Freier; Susan M. ; et al. [Ionis Pharmaceuticals, Inc.]

$ 18.00

4.8
(629)
In stock
Description

U.S. Patent Application 20190241896 for Modulators Of Dnm2 Expression

A DNM2 Centronuclear Myopathy Mutation Reveals a Link between Recycling Endosome Scission and Autophagy - ScienceDirect

EP0625986B1 - Oligothionucleotides - Google Patents

Differential impact of ubiquitous and muscle dynamin 2 isoforms in muscle physiology and centronuclear myopathy

Modulators Of Dnm2 Expression Freier; Susan M. ; et al. [Ionis Pharmaceuticals, Inc.]

WO2019089692A1 - MODULATORS OF ENaC EXPRESSION - Google Patents

Ion mobility coupled to native mass spectrometry as a relevant tool to investigate extremely small ligand-induced conformational changes - Analyst (RSC Publishing)

A Combination of Native LC-MS Approaches for the Comprehensive Characterization of the Antibody-Drug Conjugate Trastuzumab Deruxtecan

A DNM2 Centronuclear Myopathy Mutation Reveals a Link between Recycling Endosome Scission and Autophagy - ScienceDirect

EP2341057A2 - Oligonucleotide Analogues - Google Patents

IJMS, Free Full-Text

Brett P. Monia's research works Ionis Pharmaceuticals, Carlsbad and other places

US20050245475A1 - Functional and hyperfunctional siRNA directed against Bcl-2 - Google Patents

SELECT SERIES Cyclic IMS ion mobility mass spectrometer

Differential impact of ubiquitous and muscle dynamin 2 isoforms in muscle physiology and centronuclear myopathy

A DNM2 Centronuclear Myopathy Mutation Reveals a Link between Recycling Endosome Scission and Autophagy - ScienceDirect